Clinical trial
Italian Registry In the Setting of AF Ablation With Rivaroxaban
NCT04315974 is registered in ClinicalTrials.gov with Dr Carlo Lavalle as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Italian Registry In the Setting of AF Ablation With Rivaroxaban
- Lead sponsor
- Dr Carlo Lavalle
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- May 15, 2020
- Completion date
- March 31, 2022
- Enrollment
- 250 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.